Africa

Zimbabwe approves J&J coronavirus vaccine as third wave rages

Johnson & Johnson's single dose COVID-19 shot is the fourth to be endorsed for use in the EU after vaccines from Pfizer-BioNTech, AstraZeneca-Oxford University and Moderna.

Zimbabwe on Wednesday approved the US-made Johnson and Johnson Covid-19 vaccine for emergency use, the first Western-manufactured jab to be administered in the country amid a spiralling third wave of infections.

The only vaccines so far approved in the southern African country – which has frosty relationship with some western nations, including the US – are made in China, Russia and India.

But the government came under fire for turning down an African Union (AU) donation of three million J&J doses in June – citing storage issues and possible side-effects – despite surging cases and vaccine shortages.

And now, “based on the review of the submitted quality, safety and efficacy data… emergency use authorisation has been granted for (the vaccine) manufactured by Johnson and Johnson,” the Medicines Control Authority of Zimbabwe said in a letter to government seen by journalists on Wednesday.

President Emmerson Mnangagwa last year unsuccessfully asked the United Nations for support in fighting the sanctions, claiming they hurt the country’s economic development.

Just over 694 600 people in Zimbabwe have been fully vaccinated, while 1.5 million have received a first shot out of a population of 14.8 million.

To date, Zimbabwe has recorded more than 70 400 cases of Covid-19, of which at least 3 280 have been fatal

Get more stories like this on Twitter and Telegram

Recommended Stories